Glucagon-like peptide-1 agonists' effects on glycemic control, weight loss, and beta cells function in type 1 diabetes.

Front Endocrinol (Lausanne) · 2026 · PMC13013066 · PMID 41890182

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

GLP-1 agonists significantly reduced HbA1c, MD=-4.28, 95% CI , -5.06--3.49; the results were marginally significant after removing studies with high heterogeneity, MD=-0.6, 95% CI , -0.12-0.00.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.